Summary
A study published in The Lancet Public Health has found that India's antibiotic consumption is heavily skewed toward "Watch" category drugs, powerful, broad-spectrum antibiotics meant to be reserved for specific infections, while both first-line "Access" antibiotics and last-resort "Reserve" drugs remain underused. The findings echo an earlier NCDC hospital survey showing that only 6% of prescriptions were based on actual culture testing, meaning most antibiotics are being started without confirming what infection, if any, is actually present.
WHY IN NEWS FOR UPSC & STATE PCS
The Lancet Public Health study is the first global framework estimating how much of each antibiotic category countries actually need based on their infection burden and it places India's prescribing pattern sharply out of line with that estimate: overusing Watch antibiotics, underusing Access antibiotics and underusing Reserve antibiotics despite the country's high resistance burden.
Standard News
The Missing Step Before the Prescription Pad Here's the
AWaRe classification in one line: WHO sorts antibiotics into Access (safe, first-line, low resistance risk), Watch (stronger, meant only for specific infections) and Reserve (last resort, for confirmed multidrug-resistant cases).
It's a traffic-light system for how carefully a drug should be guarded. India's numbers show the light is stuck on the wrong colour: 9.3 defined daily doses of Watch antibiotics used per 1,000 people, against an ideal of 6.
Access antibiotics, meanwhile, are used at 4.5 DID against a required 7.8. That's not simply "too many antibiotics." India's overall use, 18.3 DID against an ideal 14.7, is actually closer to appropriate than the category mix suggests.
The real problem is a category swap: doctors are reaching for the strong drug first and the mild first-line drug is being underused. Why would a doctor reach for the stronger drug by default? Because the alternative is diagnosis and diagnosis takes time an emergency department or an overloaded ward doesn't have.
The NCDC's own hospital survey found only 6% of antibiotic prescriptions were based on an actual culture test confirming which organism was present. The other 94% were "empirical," a doctor's best guess at what infection this probably is, treated with a drug broad enough to cover several possibilities at once.
A Watch antibiotic is, by design, that broad-coverage guess. An Access antibiotic usually isn't, which is exactly why it's safer to overuse and riskier to under-target with. This is where the AWaRe framework earns its relevance, not as a WHO classification exercise but as a diagnostic mirror.
It doesn't just describe the problem, it locates it precisely: at the point of prescription, before any lab result comes back, in wards where 86.5% of antibiotics are still given intravenously and prescribing rates swing from 37% to 100% depending on the hospital.
That range alone tells you this isn't a drug-availability problem. It's a decision-point problem, repeated at scale, without the microbiology infrastructure to slow it down. What's actually missing isn't awareness. India has had a National Action Plan on AMR since 2017 and doctors broadly know what "Watch" and "Reserve" mean.
What's missing is the turnaround-time infrastructure, fast, affordable culture testing at the point of care, that would let a physician start narrow and confirm, instead of starting broad because narrow isn't fast enough to be practical.
For the exam, the AWaRe skew isn't just a fact to cite, it's the clearest available proxy for how far a health system still runs on guesswork instead of confirmed diagnosis and that gap is exactly what any answer on India's AMR governance should be measuring.
Quick Facts
India's actual antibiotic use is 18.3 defined daily doses per 1,000 people per day against an ideal requirement of 14.7. Only 27% of use comes from the Access category against a required 52.3%. An earlier NCDC survey across 20 tertiary hospitals found 57% of prescriptions were Watch antibiotics and only 6% were based on microbiological culture confirmation.
Common overused Watch drugs include ceftriaxone, azithromycin and ciprofloxacin. Reserve antibiotics such as meropenem and colistin should be limited to confirmed multidrug-resistant infections.
Connect the dots for your UPSC preparation.
Standard news covers the event. Log in to read our comprehensive analysis and uncover the hidden constitutional, structural, and ethical dimensions of this topic:
The specific hospital-level evidence showing why 94% of prescriptions are empirical, not diagnosis-confirmed
The full breakdown of duplicate antibiotic coverage and what it reveals about India's stewardship gaps
A concrete short-term and long-term roadmap tied to the National Action Plan on AMR
The tertiary-hospital case study showing exactly where stewardship infrastructure breaks down at the point of prescription
Included in this analysis
Join thousands of aspirants analyzing the news deeply.
Log In to Read Full ArticleDon't have an account? Sign up for free